Revocit 210mg Tablet

Revocit 210mg Tablet

Oral drugs such as Doxycycline & Ciprofloxacin have to be separated from Revocit.

Indications

Revocit is indicated in-

• The control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis.
• The treatment of iron deficiency anemia in adult patients with chronic kidney disease not on dialysis.

Pharmacology

Ferric iron binds dietary phosphate in the Gl tract and precipitates as ferric phosphate. This compound is insoluble and is excreted in the stool. By binding phosphate in the Gl tract and decreasing absorption, ferric iron lowers the phosphate concentration in the serum.

Interaction

Oral drugs such as Doxycycline & Ciprofloxacin have to be separated from Revocit.

Contraindications

Ferric Citrate is contraindicated in patients with iron overload syndrome (Hemochromatosis).

Side Effects

Most common adverse reactions are discolored feces, diarrhoea, constipation, nausea, vomiting, cough, abdominal pain and hyperkalemia.

Pregnancy & Lactation

There are no available data on Ferric Citrate use in pregnant women & Lactating mother.

Precautions & Warnings

Iron absorption from Phoscon may lead to excessive elevations in iron stores. May increase in serum ferritin and transferrin saturation (TSAT) levels. Patients may require a reduction in dose or discontinuation of intravenous iron.Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years of age. Keep Revocit out of reach of children. In case of accidental overdose, call a doctor or poison control center in hospital immediately.

Overdose Effects

No data are available regarding overdose of Revocit in patients. In patients with Chronic Kidney Disease, the maximum dose studied was 2,520 mg ferric iron per day.

Therapeutic Class

Oral Iron preparations

Storage Conditions

Store below 30°C, away from light and in a dry place. Keep out of the reach of children.